These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4608311)

  • 21. Intravenous co-trimoxazole ("Bactrim") in the treatment of acute pyelonephritis.
    Bailey RR
    Chemotherapy; 1977; 23(1):7-10. PubMed ID: 830517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Kidney function and bacteriological and histological research in the therapy of experimental E. coli pyelonephritis using trimethoprim-sulfamethoxazole (TMP-SMO)].
    Hagemann I; Briedigkeit H; Strangfeld D; Precht K; Ditscherlein G; Puls U; Neubrandt C; Pietsch R; Kruse I
    Z Urol Nephrol; 1985 Dec; 78(12):681-8. PubMed ID: 3913223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemoglobinopathy with prolonged bactermia. A report of two cases.
    Finley RA
    JAMA; 1975 Nov; 234(7):718-21. PubMed ID: 1102736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind trial to compare ampicillin, cephalexin, co-trimoxazole, and trimethoprim in treatment of urinary infection.
    Brumfitt W; Pursell R
    Br Med J; 1972 Jun; 2(5815):673-6. PubMed ID: 4555654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-trimoxazole and nitrofurantoin in urinary-tract infections: a controlled clinical study.
    Lövestad A; Sabel G; Stefansson M; Gästrin B; Lundström R
    Scand J Infect Dis Suppl; 1976; (8):58-60. PubMed ID: 779006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
    Kim KS; Anthony BF
    Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trimethoprim-sulfamethoxazole vs ampicillin in chronic urinary tract infections. A double-blind multicenter cooperative controlled study.
    Gleckman RA
    JAMA; 1975 Aug; 233(5):427-31. PubMed ID: 1097747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of some co-trimoxazole-resistant Enterobacteriaceae from infected patients.
    Barker J; Healing D; Hutchison JG
    J Clin Pathol; 1972 Dec; 25(12):1086-8. PubMed ID: 4570620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-Year Antimicrobial Resistance Patterns of Urinary Escherichia coli at an Australian Tertiary Hospital: Time Series Analyses of Prevalence Data.
    Fasugba O; Mitchell BG; Mnatzaganian G; Das A; Collignon P; Gardner A
    PLoS One; 2016; 11(10):e0164306. PubMed ID: 27711250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Failure of peroral trimethoprim/sulfamethoxazole as infection preventive agent in acute lymphatic leukemia].
    Melby K; Kolmannskog S; Flaegstad T
    Tidsskr Nor Laegeforen; 1984 Nov; 104(31):2174-5. PubMed ID: 6397875
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical experience with ofloxacin in upper and lower urinary tract infections. A comparison with co-trimoxazole and nitrofurantoin.
    Ludwig G; Pauthner H
    Drugs; 1987; 34 Suppl 1():95-9. PubMed ID: 3501751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Present status of the treatment of urological infections].
    Ukhin AV
    Antibiot Med Biotekhnol; 1985 May; 30(5):384-91. PubMed ID: 3896135
    [No Abstract]   [Full Text] [Related]  

  • 33. Scarring as a factor affecting the eradication of microorganisms from the kidney in pyelonephritis.
    Miller T
    Antimicrob Agents Chemother; 1983 Mar; 23(3):500-2. PubMed ID: 6601931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. beta-lactamase production by strains of Escherichia coli of intermediate susceptibility to beta-lactam antibiotics. A study of their clinical significance in urinary tract infection.
    Brauner A; Dornbusch K; Hallander HO
    Scand J Infect Dis Suppl; 1978; (13):67-72. PubMed ID: 356181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
    Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R
    Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended therapy in patients with established urinary tract infection.
    Lawson DH; Gleadle RI; Linton AL
    Scott Med J; 1971 Mar; 16(3):169-72. PubMed ID: 4933924
    [No Abstract]   [Full Text] [Related]  

  • 37. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
    Iravani A; Klimberg I; Briefer C; Munera C; Kowalsky SF; Echols RM
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():67-75. PubMed ID: 10225575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First-Line Antimicrobial Resistance Patterns of Escherichia coli in Children With Urinary Tract Infection in Emergency Department and Primary Care Clinics.
    Ahmed MN; Vannoy D; Frederick A; Chang S; Lawler E
    Clin Pediatr (Phila); 2016 Jan; 55(1):19-28. PubMed ID: 26040907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of chronic pyelonephritis].
    Werning C; Siegenthaler W
    Minerva Med; 1972 Oct; 63(76):4150-2. PubMed ID: 4634555
    [No Abstract]   [Full Text] [Related]  

  • 40. Nitrofurantoin: the return of an old friend in the wake of growing resistance.
    Kashanian J; Hakimian P; Blute M; Wong J; Khanna H; Wise G; Shabsigh R
    BJU Int; 2008 Dec; 102(11):1634-7. PubMed ID: 18657135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.